ANTHEM BIOSCIENCES
Back to Balance Sheet
|
ANTHEM BIOSCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹90 Cr | ₹54 Cr | ₹250 Cr | ₹226 Cr | ₹5.55 Cr |
What is the latest Contingent Liabilities ratio of ANTHEM BIOSCIENCES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹90 Cr |
| Mar2025 | ₹54 Cr |
| Mar2024 | ₹250 Cr |
| Mar2023 | ₹226 Cr |
| Mar2022 | ₹5.55 Cr |
How is Contingent Liabilities of ANTHEM BIOSCIENCES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹90 Cr | 65.69 | |
| Mar2025 | ₹54 Cr | -78.24 | |
| Mar2024 | ₹250 Cr | 10.68 | |
| Mar2023 | ₹226 Cr | 3,974.99 | |
| Mar2022 | ₹5.55 Cr | - | |
Compare Contingent Liabilities of peers of ANTHEM BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANTHEM BIOSCIENCES | ₹45,181.4 Cr | -4.7% | -12.7% | 3.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,831.0 Cr | -0.4% | -6.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹242,074.0 Cr | 0.9% | -3.3% | 39.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,355.0 Cr | 0.1% | -7.2% | 28.2% | Stock Analytics | |
| CIPLA | ₹107,439.0 Cr | -0.3% | -4% | -15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,417.0 Cr | 1.5% | 3.1% | 0.4% | Stock Analytics | |
ANTHEM BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANTHEM BIOSCIENCES | -4.7% |
-12.7% |
3.6% |
| SENSEX | 0.6% |
-1.4% |
-10.7% |
You may also like the below Video Courses